Prolonged Hypokalemia and Delayed Diagnosis of Primary Aldosteronism: Clinical Course and Risk Factors
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgad752 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Gaytri Gupta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Duke National University of Singapore (NUS) Medical School, Singapore 169857, Singapore. Hauptthemen laut MEDLINE: Hyperaldosteronism, Hypokalemia, Delayed Diagnosis, Adrenalectomy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Medical Research Council.
Abstract (Originalsprache)
Context
Primary aldosteronism (PA) is a common cause of hypertension (HT). However, diagnosis is often delayed, leading to poorer clinical outcomes. Hypokalemia with HT is characteristic of PA, and is an indication for screening.
Objective
We evaluated if patients with PA had prolonged hypokalemia before diagnosis, the subsequent biochemical/clinical control, and factors associated with delayed diagnosis.
Methods
Our study included all PA patients with hypokalemia diagnosed between 2001 and 2022. Delayed diagnosis was defined as duration of hypokalemia of more than 1 year from first occurrence to first evaluation by a PA specialist. Patients were reassessed post adrenalectomy using the Primary Aldosteronism Surgery Outcomes criteria. We performed multivariable analysis to assess for factors associated with delayed diagnosis.
Results
Among 240 patients with PA who presented with hypokalemia, 122 (51%) patients had delayed diagnosis, with prolonged hypokalemia of median duration 4.5 years (range, 2.4-7.5 years). Patients with delayed diagnosis were older, had longer duration of HT, higher pill burden, lower renal function, and more prevalent cardiovascular disease. Factors associated with delayed diagnosis included older age, presence of hyperlipidemia, and less severe hypokalemia (serum potassium >3.0 mmol/L). Compared to patients with early diagnosis, a lower proportion of those with delayed diagnosis underwent adrenal vein sampling (73% vs 58%) (P < .05). Sixty of 118 (50.8%) nondelayed, and 39 of 122 (32.0%) patients with delayed diagnosis, underwent surgery.
Conclusion
Despite manifestation of hypokalemia, many patients with PA fail to be promptly screened. Greater emphasis in HT guidelines, and efforts to improve awareness of PA among primary care physicians, are urgently needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Duke National University of Singapore (NUS) Medical School, Singapore 169857, Singapore.
- Department of Endocrinology, National University Health System, Singapore 119074, Singapore.
- Department of Endocrinology, Singapore General Hospital, Singapore 169608, Singapore.
- Department of Endocrinology, Sengkang General Hospital, Singapore 554886, Singapore.
- Department of Endocrinology, Changi General Hospital, Singapore 529889, Singapore.
- National Neuroscience Institute, Singapore 308433, Singapore.
ORCID-Profile: Matthew Chuah, Troy H Puar
Förderung
- National Medical Research Council
Zitieren
APA
Gupta, G., Teo, A. E. D., Swee, D. S., Loh, L. M., Chuah, M., Loh, W. J., Saffari, S. E., Koh, X. H., Kek, P. C., & Puar, T. H. (2024). Prolonged Hypokalemia and Delayed Diagnosis of Primary Aldosteronism: Clinical Course and Risk Factors. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad752
Vancouver
Gupta G, Teo AED, Swee DS, Loh LM, Chuah M, Loh WJ, et al. Prolonged Hypokalemia and Delayed Diagnosis of Primary Aldosteronism: Clinical Course and Risk Factors. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad752
BibTeX
@article{Gupta2024,
author = {Gupta, Gaytri and Teo, Ada E D and Swee, Du Soon and Loh, Lih Ming and Chuah, Matthew and Loh, Wann Jia and Saffari, Seyed Ehsan and Koh, Xuan Han and Kek, Peng Chin and Puar, Troy H},
title = {Prolonged Hypokalemia and Delayed Diagnosis of Primary Aldosteronism: Clinical Course and Risk Factors},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgad752}
}
EUVIMED